[ CARE AND USE MANUAL ]
ACQUITY UPLC Peptide HSS T3, 100Å Columns
CONTENTS
I.
INTRODUCTION
II.
II.
III.
IV.
V.
VI.
VII.
I. INTRODUCTION
Thank you for choosing a Waters® ACQUITY UPLC® Peptide
HSS T3, 100Å Column that contains our High Strength Silica
particle technology to deliver increased peptide retentivity
and different selectivity compared to results generated on
the Peptide CSH™ C
, 130Å or Peptide BEH C
18
300Å Column offerings. The manufacture of our Peptide
HSS T3 particles begins with ultrapure reagents to control
the chemical composition and purity of the final product.
Peptide HSS T3 columns are manufactured in a cGMP, ISO
9001:2000 certified plant with each step being conducted
within narrow tolerances. Each batch of ACQUITY UPLC
HSS T3, 100Å material is chromatographically tested with
acidic, basic, and neutral analytes, as well part of Waters'
standard batch qualification procedure. In addition, each
batch of HSS T3, 100Å material is QC tested with a gradient
separation of a tryptic digest of cytochrome c and must pass
stringent performance criteria before acceptance for use in
an ACQUITY UPLC Peptide HSS T3, 100Å Column. A final
QC test for packed bed efficiency is also performed on each
column with this as well as the batch test results provided on
the column's attached eCord™ Intelligent Chip.
ACQUITY UPLC Peptide HSS T3, 100Å Columns were designed
and tested specifically for use on ACQUITY UPLC Systems and
will deliver maximum chromatographic performance when
used on the holistically-designed ACQUITY UPLC System.
, 130Å and
18
1